Stocktoria
INTERPACE BIOSCIENCES, INC. IDXG
OTC · OOTC · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1998-05-19
INTERPACE BIOSCIENCES, INC. statistics & valuation
Market cap$46.5M
P / E1.9×
P / S1.2×
P / B2.1×
P / FCF8.5×
Net margin63.5%
Return on equity109.9%
FCF margin14.1%
Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 62.3% | 63.8% | 62.6% | 57.3% | 56.8% | 33.1% | 34.4% | 53.4% | 53.7% | 49.2% |
| Operating margin | 10.5% | 17.3% | 9.9% | -11.4% | -19.1% | -80.5% | -109.1% | -55.3% | -39.6% | -49.2% |
| Net margin | 63.5% | 14.3% | 4.9% | -69.0% | -45.1% | -81.6% | -110.4% | -55.7% | -76.8% | -63.7% |
| FCF margin | 14.1% | 8.0% | 8.3% | -25.2% | -27.4% | -48.0% | -78.8% | -41.7% | -96.2% | — |
| Return on assets | 72.6% | 45.3% | 14.9% | -137.4% | -38.9% | -57.9% | -51.9% | -25.2% | -22.8% | -19.9% |
| Return on equity | 109.9% | -302.3% | -3.5% | 37.8% | 35.2% | 91.0% | 597.0% | -78.9% | -30.6% | -20.9% |
| Debt / equity | — | — | — | — | — | — | — | — | — | 0.20× |
| Current ratio | 1.94 | 1.11 | 0.91 | 0.85 | 0.78 | 0.77 | 0.95 | 2.09 | 2.45 | 0.26 |
Source: SEC EDGAR filings · CIK 0001054102 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.